Chemours

NYSE: CC · Real-Time Price · USD
14.72
-0.35 (-2.32%)
At close: Aug 15, 2025, 10:01 AM

Chemours Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
86M -238M 578M 608M
Depreciation & Amortization
301M 307M 291M 317M
Stock-Based Compensation
15M 19M 27M 34M
Other Working Capital
-745M 634M -299M 252M
Other Non-Cash Items
44M 6M -58M -89M
Deferred Income Tax
-27M -158M 20M -77M
Change in Working Capital
-1.05B 620M -104M 27M
Operating Cash Flow
-633M 556M 754M 820M
Capital Expenditures
-360M -370M -307M -277M
Cash Acquisitions
n/a n/a 33M 508M
Purchase of Investments
n/a n/a n/a -12M
Sales Maturities Of Investments
n/a n/a n/a -508M
Other Investing Acitivies
7M 141M -10M 509M
Investing Cash Flow
-353M -229M -284M 220M
Debt Repayment
95M 393M -79M -208M
Common Stock Repurchased
-3M -69M -495M -173M
Dividend Paid
-148M -149M -154M -164M
Other Financial Acitivies
8M 16M -8M -15M
Financial Cash Flow
-36M 172M -685M -560M
Net Cash Flow
-1.04B 503M -247M 446M
Free Cash Flow
-993M 186M 447M 543M